Sara Tinsley

Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison

Kristin M. Phillips, Javier Pinilla‐Ibarz, Eduardo M. Sotomayor et al. · Supportive Care in Cancer · 2012 · 122 citations · Full text

Hematological Malignancy, Quality Of Life, Chronic Myeloid Leukemia +12

A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)

Eric Padron, Amy E. DeZern, Marcio Andrade‐Campos et al. · Clinical Cancer Research · 2016 · 95 citations · Full text

Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)

Gregory A. Abel, Fabio Efficace, Rena Buckstein et al. · Haematologica · 2016 · 77 citations · Full text

A preliminary controlled trial of a trans‐diagnostic programme for cognitive behaviour therapy with adults with intellectual disability

William R. Lindsay, Sara Tinsley, Nigel Beail et al. · Journal of Intellectual Disability Research · 2014 · 46 citations

A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes

Rami S. Komrokji, Sheng Wei, Adam W. Mailloux et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 40 citations

Hematological Malignancy, Bone Marrow Failure, Medicine +9